Target intelligence / Profile preview

Hepatitis B virus RNA transcripts (S and X genes) (HBV S/X RNA)

Target
HBV S/X RNA
Molecular classification
Viral RNA, Nucleic acid
01

Overview

Hepatitis B virus (HBV) RNA transcripts from the S and X genes are essential for the viral life cycle and the maintenance of chronic infection (Seeger & Mason, 2000, Microbiology and Molecular Biology Reviews). The S gene transcripts encode the surface antigens (HBsAg), which are produced in vast excess to decoy the host immune system, while the X gene transcript encodes the HBx protein, a transactivator necessary for viral replication and a key factor in the development of hepatocellular carcinoma (Lucifora & Protzer, 2016, Journal of Hepatology). Because the HBV genome is organized into overlapping open reading frames, targeting the S and X regions with antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) allows for the simultaneous degradation of multiple viral RNA species, including the pregenomic RNA (pgRNA) (Wooddell et al., 2017, Science Translational Medicine). This therapeutic strategy, employed by drugs like Bepirovirsen and JNJ-3989, aims to significantly reduce viral protein load, particularly HBsAg, to facilitate the restoration of the host's innate and adaptive immune responses (Yuen et al., 2021, Nature Medicine). Achieving such a reduction is considered a critical step toward a functional cure for chronic hepatitis B, potentially preventing progression to cirrhosis and liver cancer.

Other names
HBV S and X gene transcriptsHepatitis B virus mRNAHBV subgenomic RNAHBV S-ORF and X-ORF transcriptsHBV RNA
02

Mechanism of action

Antisense oligonucleotide-mediated RNase H cleavage or RNA interference (RNAi) leading to sequence-specific degradation of viral mRNA and reduction of viral protein production.

03

Biological functions

Viral protein synthesisViral replicationImmune evasionOncogenesis
04

Disease associations

Chronic Hepatitis BHepatocellular carcinomaLiver cirrhosisInfection
05

Safety considerations

Transient ALT elevations (flares)Injection site reactionsPotential off-target hybridizationLong-term safety of RNA-based therapies
06

Interacting drugs

Bepirovirsen (GSK3228836)

4 more in the full profile.

07

Biomarkers

Hepatitis B surface antigen (HBsAg) levelsHBV DNASerum HBV RNAAlanine aminotransferase (ALT) levels

Beyond the preview

Go deeper on Hepatitis B virus RNA transcripts (S and X genes) (HBV S/X RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus RNA transcripts (S and X genes) (HBV S/X RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call